prompting-renewed
Abbott diet drug study renews calls for U.S. ban (Reuters)
September 2, 2010 by admin · Leave a Comment
Reuters – A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.
Originally posted here:
Abbott diet drug study renews calls for U.S. ban
(Reuters)
prompting-renewed
Abbott’s diet drug study renews calls for U.S. ban (Reuters)
September 2, 2010 by publisher · Leave a Comment
Reuters – A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.
Original post:
Abbott’s diet drug study renews calls for U.S. ban
(Reuters)
prompting-renewed
Corrected: Abbott’s diet drug study renews calls for U.S. ban (Reuters)
September 1, 2010 by admin · Leave a Comment
Reuters – A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.
Original post:
Corrected: Abbott’s diet drug study renews calls for U.S. ban
(Reuters)